Literature DB >> 12184788

Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats.

Xiaofeng Meng1, Shengmin Sang, Nanqun Zhu, Hong Lu, Shuqun Sheng, Mao-Jung Lee, Chi-Tang Ho, Chung S Yang.   

Abstract

(-)-Epigallocatechin gallate (EGCG), the most abundant tea catechin, has been proposed to be beneficial to human health based on its strong antioxidative and other biological activities in vitro. Inadequate knowledge regarding the bioavailability and biotransformation of EGCG in humans, however, has limited our understanding of its possible beneficial health effects. In this study, 4',4' '-di-O-methyl-EGCG (4',4' '-DiMeEGCG) was detected in human plasma and urine by LC/MS/MS following green tea ingestion. Both 4',4' '-DiMeEGCG and EGCG reached peak plasma values (20.5 +/- 7.7 and 145.4 +/- 31.6 nM, respectively, in 4 subjects) at 2 h after the dose. The half-lives of 4',4' '-DiMeEGCG and EGCG were 4.1 +/- 0.8 and 2.7 +/- 0.9 h, respectively. The cumulative urinary excretion of 4',4' '-DiMeEGCG during a 24 h period was 140.3 +/- 48.6 microg, about 5-fold higher than that of EGCG, but the excreted 4',4' '-DiMeEGCG and EGCG in urine only accounted for about 0.1% of ingested EGCG. (-)-5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone (M4) and (-)-5-(3',4'-dihydroxyphenyl)-gamma-valerolactone (M6), along with another possible ring-fission metabolite, (-)-5-(3',5'-dihydroxyphenyl)-gamma-valerolactone (M6'), were detected in human urine after green tea ingestion. The cumulative excretion of M4, M6', and M6 during a 24 h period ranged from 75 microg to 1.2 mg, 0.6 to 6 mg, and 0.6 to 10 mg, respectively. The combined excretion of all three ring-fission metabolites accounted for 1.5-16% of ingested catechins. M4, M6', and M6 were all observed after the ingestion of pure EGCG or EGC by human subjects, whereas only M6 was produced after EC ingestion. These metabolites as well as monomethylated EGCG were detected in mice and rats after tea or EGCG administration, and the tissue levels reflected the rather low bioavailability of EGCG in rats. The presently characterized methylated EGCG metabolites and ring-fission products exist in substantial quantities and may contribute to the biological activities of tea.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184788     DOI: 10.1021/tx010184a

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  38 in total

Review 1.  Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components.

Authors:  Y Li; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

2.  Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.

Authors:  Piwen Wang; William J Aronson; Min Huang; Yanjun Zhang; Ru-Po Lee; David Heber; Susanne M Henning
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

3.  Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers.

Authors:  Maki Inoue-Choi; Jian-Min Yuan; Chung S Yang; David J Van Den Berg; Mao-Jung Lee; Yu-Tang Gao; Mimi C Yu
Journal:  Int J Mol Epidemiol Genet       Date:  2010

Review 4.  Pharmacokinetic and chemoprevention studies on tea in humans.

Authors:  H-H Sherry Chow; Iman A Hakim
Journal:  Pharmacol Res       Date:  2011-05-20       Impact factor: 7.658

5.  A high-fat high-sucrose diet affects the long-term metabolic fate of grape proanthocyanidins in rats.

Authors:  Eunice Molinar-Toribio; Elisabet Fuguet; Sara Ramos-Romero; Núria Taltavull; Lucía Méndez; M Rosa Nogués; Isabel Medina; Josep Lluís Torres; Jara Pérez-Jiménez
Journal:  Eur J Nutr       Date:  2016-10-12       Impact factor: 5.614

Review 6.  Epigenetic effects of green tea polyphenols in cancer.

Authors:  Susanne M Henning; Piwen Wang; Catherine L Carpenter; David Heber
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

7.  Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.

Authors:  Daire O'Shea; John Law; Adrian Egli; Donna Douglas; Gary Lund; Sarah Forester; Joshua Lambert; Mansun Law; Dennis R Burton; D L J Tyrrell; Michael Houghton; Atul Humar; Norman Kneteman
Journal:  Liver Transpl       Date:  2016-01-29       Impact factor: 5.799

8.  Structural identification of novel glucoside and glucuronide metabolites of (-)-epigallocatechin-3-gallate in mouse urine using liquid chromatography/electrospray ionization tandem mass spectrometry.

Authors:  Shengmin Sang; Chung S Yang
Journal:  Rapid Commun Mass Spectrom       Date:  2008-11       Impact factor: 2.419

Review 9.  The challenge of developing green tea polyphenols as therapeutic agents.

Authors:  C Huo; S B Wan; W H Lam; L Li; Z Wang; K R Landis-Piwowar; D Chen; Q P Dou; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

10.  N- and S-homocysteinylation reduce the binding of human serum albumin to catechins.

Authors:  Angelo Zinellu; Salvatore Sotgia; Bastianina Scanu; Dionigia Arru; Annalisa Cossu; Anna Maria Posadino; Roberta Giordo; Arduino A Mangoni; Gianfranco Pintus; Ciriaco Carru
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.